↓ Skip to main content

Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative…

Overview of attention for article published in Cancer Management and Research, January 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
3 X users
facebook
1 Facebook page

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
30 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addressing physician barriers to administering cyclin-dependent kinases 4 and 6 inhibitors in first-line treatment of hormone receptor–positive, human epidermal growth factor receptor 2–negative advanced breast cancer
Published in
Cancer Management and Research, January 2019
DOI 10.2147/cmar.s186658
Pubmed ID
Authors

Reshma L Mahtani, Charles L Vogel

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 30 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 10%
Other 3 10%
Student > Master 3 10%
Student > Doctoral Student 2 7%
Student > Postgraduate 2 7%
Other 4 13%
Unknown 13 43%
Readers by discipline Count As %
Medicine and Dentistry 7 23%
Biochemistry, Genetics and Molecular Biology 1 3%
Mathematics 1 3%
Unspecified 1 3%
Agricultural and Biological Sciences 1 3%
Other 3 10%
Unknown 16 53%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2019.
All research outputs
#13,398,743
of 23,120,280 outputs
Outputs from Cancer Management and Research
#461
of 2,018 outputs
Outputs of similar age
#210,163
of 438,245 outputs
Outputs of similar age from Cancer Management and Research
#20
of 89 outputs
Altmetric has tracked 23,120,280 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,018 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,245 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.